In vitro activity of BMY-28100 against common isolates from pediatric infections.
The antibacterial activity of BMY-28100, a new oral cephalosporin, was measured against 300 bacterial isolates from pediatric infections by standard agar dilution methodology. The effect of inoculum size on activity was also assessed. BMY-28100 was more active than cephalexin or cefaclor against all...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1987
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3606067/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.4.630 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
